E. Courbon

Placental Transfer of Maraviroc in an Ex Vivo Human Cotyledon Perfusion Model and Influence of ABC Transporter Expression

L. Mandelbrot, G. Peytavin, X. Declèves, 2013, Antimicrobial Agents and Chemotherapy.

Switching to darunavir/ritonavir 800/100 mg once‐daily containing regimen maintains virological control in fully suppressed pre‐treated patients infected with HIV‐1

C. Katlama, L. Schneider, R. Murphy, 2013, Journal of medical virology.

A Coding Variant in RARG Confers Susceptibility to Anthracycline-Induced Cardiotoxicity in Childhood Cancer

Smita H. Karande, C. Portwine, D. Johnston, 2015, Nature Genetics.

Etravirine Concentrations in the Cervicovaginal Compartment in HIV-1-Infected Women Receiving Etravirine-Containing Antiretroviral Therapy: DIVA 02 Study

R. Tubiana, C. Katlama, L. Mandelbrot, 2012, Antimicrobial Agents and Chemotherapy.

Switching to darunavir/ritonavir 800/100 mg once‐daily containing regimen maintains virological control in fully suppressed pre‐treated patients infected with HIV‐1

C. Katlama, L. Schneider, R. Murphy, 2013, Journal of medical virology.

Switch From Etravirine Twice Daily to Once Daily in Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Resistant HIV-Infected Patients With Suppressed Viremia: The Monetra Study

V. Calvez, C. Katlama, G. Peytavin, 2012, HIV clinical trials.